| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c76da50ee11acf8b1053798f7d36e643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ddac69d50e35aed47d60cc8d7459c26 |
| publicationDate |
2005-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005107346-A1 |
| titleOfInvention |
N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity |
| abstract |
The invention relates to a method for the production of a vascular damaging effect in a warm-blooded animal such as a human, which comprises administering to said animal an effective amount of ZD6126 or a pharmaceutically NHCOCH acceptable salt thereof, before, after or simultaneously with an effective amount of one of the following therapies: i) ionising radiation; ii) a platinum anti-tumour agent; and iii) a taxane. The invention also relates to the use of ZD6126 and one of the above therapies in the manufacture of a medicament for use in the production of a vascular damaging effect in a warm-blooded animal such as a human and to pharmaceutical compositions and kits each comprising ZD6126 and one of a platinum anti-tumour agent and a taxane. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004053882-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168662-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173686-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009275549-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010260832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011052581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010178328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009197854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010310661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033528-A1 |
| priorityDate |
2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |